Hutch News
Results per Page:
Cross-neutralizing Monoclonal Antibodies Against Respiratory Viruses
From the Boonyaratanakornkit, Taylor and Pancera labs, Vaccine and Infectious Disease Division and Cancer Immunology Program, Cancer Consortium
High’d and seek: drug-specific antibodies to treat addiction and prevent overdose
From the Pancera Lab, Vaccine and Infectious Disease Division
Optimizing antigen design may improve HIV vaccine efforts
From the Pancera, McElrath and Stamatatos labs, Vaccine and Infectious Disease and Clinical Research Divisions
Do viruses have heads, shoulders, knees, and toes?
From the Stamatatos, Pancera and McGuire labs, Vaccine and Infectious Disease Division
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
All immunogens are not created equal
From the Stamatatos lab, Vaccine and Infectious Disease Division
Scientists map structure of potent antibody against coronavirus
Computer-generated images show why immune protein neutralizes SARS-CoV-2
Hutch team hunts for coronavirus antibodies
Screening blood from survivors to find immune proteins for treatments and guide vaccine research
Creating antibodies with antibodies
From the McGuire, Taylor, and Stamatatos labs, Vaccine and Infectious Disease Division
Modified HIV immunogens engage neutralizing antibody precursors
From the Stamatatos lab, Vaccine and Infectious Disease Division
First human antibody found to block Epstein-Barr virus
Early research could open new path for vaccine against EBV-related cancers, mononucleosis
Finding malaria’s Achilles’ heel
From the Pancera Group, Vaccine and Infectious Disease Division
New antibody and unique binding site offer possible paths to malaria prevention
Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design